Keros Therapeutics, Inc. (KROS)

SEC filing

Keros Therapeutics, Inc.

KROS · CIK 1664710

4 · Mar 11, 2026 · BIENAIME JEAN JACQUES bought 2,000 shares at $11.21/share ($22,420)

BIENAIME JEAN JACQUES bought 2,000 shares at $11.21/share ($22,420)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.